Research Crisis

The end of the baseball "lockout" last April marked the survival of a crisis for owners, players, sponsors, sportswriters, announcers, and fans. The season was played out, and the lockout will soon be forgotten. In striking contrast, the lockout of scientists working on research ranging from fundamental understandings of life processes to specific cures of literally hundreds of diseases that affect all of us (including aging and death) has increased to beyond the crisis level. This coming year

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The end of the baseball "lockout" last April marked the survival of a crisis for owners, players, sponsors, sportswriters, announcers, and fans. The season was played out, and the lockout will soon be forgotten.

In striking contrast, the lockout of scientists working on research ranging from fundamental understandings of life processes to specific cures of literally hundreds of diseases that affect all of us (including aging and death) has increased to beyond the crisis level.

This coming year, greater than 80 percent of all biomedical scientists who depend on government funds to continue their work, as well as to support their own salaries, will be locked out of jobs. This will cause them to either leave research completely or somehow try to hang on till the lockout is ended. However, since they don't belong to a union, and therefore do not have contingency moneys, their ability to hang on becomes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Theodore Lampidis

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo